Research Interest

School of Medicine

Dr. Good has served as the Director of Liver Diseases at Nassau County Medical Center and was for many years Chief, Division of Gastroenterology, Department of Medicine at South Nassau Communities Hospital. Dr. Good is an assistant clinical professor of medicine at SUNY Stony Brook. He has given hundreds of lectures in his field and has authored numerous papers and abstracts. Recently, Dr. Good presented the ACG Theater lecture at the American College of Gastroenterology annual meeting in Chicago, Illinois in October, 2014. Dr. Good was Chief Medical Officer at Ritter harmaceuticals in Los Angeles, California, where he expanded his research interest in the intestinal microbiome. Dr. Good’s current clinical research activities involve the microbiome, inflammatory bowel disease, irritable bowel syndrome and the application of orally administered gamma globulin to patients with acute and chronic gastro-intestinal disorders.

Research Interest

Gastroenterology

Jayapal Reddy Mallareddy received his Master’s degree in Chemistry from University of Hyderabad, India. After his Master’s degree he was selected for one year International Training Course on Methods in Modern Molecular Biology at Biological Research Centre (BRC) of the Hungarian Academy of Sciences in Szeged, Hungary. He received his Doctoral degree in Medicinal Chemistry for synthesis and pharmacological characterization of novel opioid ligands as therapeutic drugs. His excellence of research has been recognized through the award of the “Kisfaludy Lajos Alapitvany” prize, a foundation supporting young talented scientists in modern pharmaceutical research (Hungary). He also awarded prestigious ‘Marie- Curie’ Fellowship from the European Union for career development, where he exposed to the area of Chemical Biology developing protein-protein interaction inhibitors in University of Leeds, UK.

Research Interest

Medicinal Chemistry; Organic Chemistry

Dr. Sarkar has been a Distinguished Professor in the Departments of Pathology and Oncology at Karmanos Cancer Institute, Wayne State University School of Medicine (Retired in January, 2016) who started his scientific career in 1978 when he completed his Ph.D. thesis work. Dr. Sarkar’s early research, which continued, has been focused on understanding the role of a “master” transcription factor, NF-B, and the regulation of its upstream and downstream signaling molecules in solid tumors, and especially focusing on tumor microenvironment. Moreover, his research has been directed toward elucidating the molecular mechanism(s) of action of “natural agents”, and their synthetic analogues, in addition to other synthetic small molecule inhibitors of Bcl-2 and MDM2 for cancer prevention and therapy. The discoveries from in vitro and in vivo preclinical studies led to the design and execution of multiple Phase I/II clinical trials in breast, pancreas and prostate cancer for assessing the effects of several “natural agents” in the alterations of biomarkers as well as for assessing some early clinical efficacy. Dr. Sarkar’s research led to the concept of chemo-sensitization of cancer cells by reversing their drug-resistance phenotype to conventional therapeutics (chemo-radio-therapy) by natural agents. All studies were focused on tumor microenvironment, system biology and integrated holistic approach which led to clinical trials conducted at the Karmanos Cancer Institute. The innovation of his basic science research has attracted clinicians to collaborate with him, which clearly documents his leadership in translational research. Dr. Sarkar published 567 articles as listed in the pubmed.com, and also published over 100 review articles and book chapters. He also edited four books and serves in the editorial boards of halfdozen scientific journals.

Research Interest

Interests in petrochemical and agrochemical industries/ manufacturing/general industrial/environmental/workplace covering a wide range of classes of chemicals including pesticides, solvents, heavy metals, irritants, particulates, carcinogens, pharmaceuticals, illicit substances. Research currently centers on respiratory irritants and the expression of biomarkers of inflammation and oxidative stress from exposures to chemical agents.

Research Interest

Toxicology

Dr. Asim Ahmed Elnour has received his PhD and MSc in clinical pharmacy from School of Pharmacy, Queen’s University Belfast, N. Ireland-United Kingdom during the period of 2000-2004 and 1996 -1998, respectively. Currently, he is Pharmacy Program Lead at Fatima College of Health Sciences, Al Ain-United Arab EMIRATES-UAE. He is serving as an editorial member of several reputed journals like Journal of Medicine (Baltimore), Institute of Research Engineers and doctors, Journal of Pharmacy Research, International Journal of Biomedical Sciences and Bioinformatics, Symbiosis Journal of Pharmacy and Pharmaceutical Sciences, Pharmacology and Pharmacy, International Journal of Medical Sciences and Biotechnology. He has authored more than 100 research articles, reviews, short communications, meta-analysis and editorial letters. He is well known external examiner at pharmacy colleges. He is a member of several professional and therapeutics committees like: UAE University Research Ethics Committee, Al Ain hospital Research Ethics Committee, FCHS research Committee, Clinical Pharmacy Council, SEHA, Abu Dhabi and Team Leader of Pharmacy and Therapeutic Committee (PTC), Drug Utilization Evaluation Subcommittee (DUES) and others. He has supervised 10 Master degree gardauetes and 2 PhD graduates.

Research Interest

Clinical pharmacy Education, Clinical Pharmacy Implementation, Clinical Pharmacy Bed-Side teaching , Evidence-based pharmacy practice , Improving clinical pharmacist role in patient outcomes, Enrich the clinical pharmacy practice, Improves pharmaceutical care, Link clinical pharmacy learning and current practice, Incorporate internationally (USA experiences) developed clinical pharmacy curriculum into local pharmacy colleges.

Dr Radwan is a graduate of the U.K where he received his master & doctorate degrees from Middlesex University in London .He also holds a first degree in Pharmacy & Pharmaceutical sciences from Cairo University.He is an Adjunct Professor of Management at Edinburgh Business School; Herriot Watt University in the UK & the American University in Cairo. Ahmed is also the Chairman & CEO of Pioneera Health Care Group. He has over 25 years of experience within the pharmaceutical sector, including ethical pharmaceuticals, OTC, generics and strategic management consultation in the pharmaceutical field. His experience included French, German, Japanese, Swiss & British multinational pharmaceutical companies. Previous positions held; Marketing Director of Novartis, Regional Marketing Director of Otsuka and Regional Marketing Director of GSK. He also assumed the position of Managing Director at two major local companies .

Research Interest

Biosimilars , Pharmaceutical Industry Trends, Generic Drugs, Strategic Pharmaceutical Management

President Chen obtained PhD in 1999 at Kaohsiung Medical University. Currently teaches in Fooyin University, as most young is also the most senior professors and deans. The past 20 years, he has his scientific interests focused on life-threatening diseases, including traditional Chinese medicine used for cancer research. Analysis in recent year’s major active ingredients such as ginger, pepper and cinnamon used in gastrointestinal cancer, anti-inflammatory, antioxidant, antiparasitic, and other topics. President Chen specializes in isolation, purification and structural analysis of active components of plants. President Chen directed against active constituents of oral cancer, liver cancer, and rectal cancer. President Chen was just over 45 years old, but his work has more than 220 papers, Taiwan one of the young talents. Professor Chen was invited more than 170 kinds of Journal editorial boards. Professor Chen won numerous awards at home and abroad, from 2015, was awarded the lifetime achievement award; from 2016 was awarded the health care & biotechnology merit award.

Research Interest

Pharmacognosy, Natural Products, Chinese Medicine, Natural Product Research

I (born 1933) directed the Gastroenterology Research Unit, a third level referral center in the department of Pediatrics of the University of Florence (Meyer hospital) from 1965 to 2000. In Tuscany I first diagnosed celiac disease by the Watson capsule. I worked at the Cornell University for a joined research with the University of Florence on energy expenditure in children. A long term strategy was designed with Giuliano Parrini, prof. of Physics (Firenze, It), Andrea Giommi, prof. of Statistics (Firenze, It), and Cutberto Garza, Boston College, Rector. Three students came from Amsterdam Medical Center to learn “Initial Hunger (IH)”. The Unit published 150 scientific articles, more than 50 in international Press.

Research Interest

Loss of hunger sensations as cause of alimentary diabetes and malnutrition

Research Interest

Professor Abel Vieira is born in Lisbon, Portugal, in 1951. He obtained his Graduation in Chemical Engineering in 1974 at Instituto Superior Técnico (Lisbon), his PhD in Chemistry in 1988 at Universidade Técnica de Lisboa and his Habilitation in Chemistry, speciality Organic Chemistry in 2011 at Universidade Nova de Lisboa. In both Universities he has been professor of several disciplines in the area of Organic Chemistry. His main research interests are in the area of Physical Organic Chemistry, Radical Chemistry and Radiation Chemistry. He integrates a research group in Green Chemistry at Universidade Nova de Lisboa – LAQV-REQUIMTE – where he runs his own research group (Oxidative stress and Antioxidants) and keeps several collaborations with other portuguese and foreign groups, mainly in France and Germany. He supervised several PhD and Post-Doc students, is a referee of international peer reviewed journals and member of Scientific Societies, such as the Portuguese Chemical Society, where he was the head of the Free Radicals Group. He participated in / organized national and international scientific conferences, was a member of a European COST Action and published in high IF journals (see list of publications). Professor Vieira, besides his mother language, Portuguese, is fluent in French, German and English.

Research Interest

Organic Chemistry are Radiation Chemistry and Antioxidants

I hold a Bachelor degree in Physics from the Faculty of Physics, University of Havana (Cuba, 1995), Master degree in Physics from the Faculty of Physics, University of Havana (Cuba, 1996) and a Ph.D. in Physics from the Institute of Physics, Federal Fluminense University (Brazil, 2001). Have experience in Condensed Matter Physics and Computational Modelling. Currently, have as main research lines the study of electronic properties of nanostructures and the molecular modelling of organic and inorganic systems including the modelling of drugs (rational drug design, fragmentbased drug design, and de novo design), molecular docking, and studies on polymorphism of pharmaceutical solids.

Research Interest

Computational modeling of molecules; Drug design using in sillico tools fragment based drug design de novo design; Molecular docking

Tawfiq Arafat is currently associated with the University of Petra, Amman, Jordan. His research focus has been pharmacokinetic study of different release patterns of anti diabetic drugs in human body.

Research Interest

Tawfiq Arafat is currently associated with the University of Petra, Amman, Jordan. His research focus has been pharmacokinetic study of different release patterns of anti diabetic drugs in human body.

Carlos Horacio Laino received his PhD degree in Pharmacology from University of Buenos Aires, Argentina and completed his Post-graduate studies in the laboratory of the Research Department of Neuroscience, Center for Addiction and Mental Health, Research Foundation of Toronto, Canada. Then, he joined the National University of La Rioja (Argentina) in 2005 and is currently an Associate Professor of Pharmacology and Toxicology. He further received an award for Innovative Research Work from the National Innovation Submit & Showcase Tech Connect World in 2013 and 2014. His research focuses on drug discovery in several therapeutic areas, especially pain.

Research Interest

Biotechnology, pharmacology and drug discovery in the field of pain, depression and anxiety.

Nawal M. Khalafallah obtained a BSc and PhD in pharmaceutical Sciences (Pharmaceutics) from the Faculty of Pharmacy, Alexandria University, in Alexandria, Egypt. Spent a postoctoral year in SUNY AB in the United States working under the supervision of Professor William Jusko. Publications over the past years moved from pharmacokinetics, and drug biodistribution in animal models to improving drug product peformance using various drug delivery systems including lipid vesicular sytems, and solid lipid and polymer nanosytems among others.

Research Interest

Pharmaceutics

Research Interest